Evidence archive · record 100101

Semaglutide certificate
from Lumi Peptides.

The reported measurements and known evidence gaps are public. Pro opens the original document, upstream verification trail and surrounding batch history.

Public evidence summaryActual record data · not an example
VendorLumi PeptidesView vendor dossier
CompoundSemaglutide
Test date2026-08-27
Testing labFreedom Diagnostics
Source archiveFreedom Diagnostic
TitrateLab recordTL-COA-100101
Could this match the product you bought?Add the code, dose, cap and purchase date to search for related public reports.
Find related reports

Laboratory measurements

What this COA reports

TitrateLab COA 100101 records a laboratory report for Semaglutide attributed to Lumi Peptides, tested 2026-08-27 by Freedom Diagnostics. It reports 99.34% purity, 0.47 mg measured quantity, endotoxin result: Pass. Unreported fields remain unknown; this record does not verify untested batches.

Evidence dated 2026-08-27

Reported measurementsPublic summary
PurityChemical purity reported on the certificate
99.34%
Measured fillQuantity reported by the testing lab
0.47 mg
Dose accuracyMeasured quantity compared with the label claim
Not reported
EndotoxinReported endotoxin result, when tested
Pass
Batch / lotIdentifier printed on or attributed to this report
Light Blue Cap
Assay methodTesting method recorded for this result
HPLC + MS
Certificate scanOriginal report and upstream verification trail
Evidence limitations
  • Dose accuracy versus the label could not be calculated.
Pro evidence trail: open the original certificate, upstream verification link, related records and vendor history.
All Semaglutide Certificate of Analysis results (2,174 COAs) How to check this certificate COA verification guide Over-filled, or short-changed? What 15,167 COAs say about grey-market peptide dosing TitrateLab analysis